• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向产超广谱β-内酰胺酶肺炎克雷伯菌的噬菌体MY02的分离、鉴定及基因组分析

Isolation, characterization, and genomic analysis of phage MY02 targeting extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.

作者信息

Wang Mengya, Jiang Hailin, Wang Chuhan, Zhao Chunyan, Li Jinghua, Sun Yanbo, Yu Xin, Huang Honglan

机构信息

Department of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun, China.

出版信息

Arch Virol. 2025 Apr 9;170(5):95. doi: 10.1007/s00705-025-06281-x.

DOI:10.1007/s00705-025-06281-x
PMID:40205140
Abstract

Abuse of antibiotics has led to increased rates of resistance in extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae and an acceleration in the emergence of drug-resistant strains, which can have serious consequences for nosocomial infections. In this study, phage MY02, which infects ESBL-producing Klebsiella pneumoniae, was isolated from sewage and characterized. Phage MY02 was found to have an optimal multiplicity of infection of 0.001, with a lysis period of up to 40 minutes and an average burst of about 80 plaque-forming units per cell. The phage was found to be stable over a temperature range of -20 to 60°C and a pH range of 3-11 and to have a broad host range. Whole-genome sequencing showed that the genome of phage MY02 is ??171,821?? bp in length and contains 293 open reading frames. Sequence comparisons and phylogenetic analysis showed that phage MY02 belongs to the genus Marfavirus in the class Caudoviricetes. This novel broad-spectrum Klebsiella pneumoniae phage has potential applications against bacterial infections.

摘要

抗生素的滥用导致产超广谱β-内酰胺酶(ESBL)的肺炎克雷伯菌耐药率上升,耐药菌株的出现加速,这可能对医院感染产生严重后果。在本研究中,从污水中分离并鉴定了感染产ESBL肺炎克雷伯菌的噬菌体MY02。发现噬菌体MY02的最佳感染复数为0.001,裂解期长达40分钟,每个细胞平均爆发约80个噬菌斑形成单位。该噬菌体在-20至60°C的温度范围和3-11的pH范围内稳定,且宿主范围广泛。全基因组测序表明,噬菌体MY02的基因组长度为171,821 bp,包含293个开放阅读框。序列比较和系统发育分析表明,噬菌体MY02属于长尾噬菌体科的马尔法病毒属。这种新型广谱肺炎克雷伯菌噬菌体在对抗细菌感染方面具有潜在应用价值。

相似文献

1
Isolation, characterization, and genomic analysis of phage MY02 targeting extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.靶向产超广谱β-内酰胺酶肺炎克雷伯菌的噬菌体MY02的分离、鉴定及基因组分析
Arch Virol. 2025 Apr 9;170(5):95. doi: 10.1007/s00705-025-06281-x.
2
Characterization of two lytic bacteriophages infecting carbapenem-resistant clinical Klebsiella pneumoniae in Dhaka, Bangladesh.孟加拉国达卡两种感染耐碳青霉烯类临床肺炎克雷伯菌的裂解性噬菌体的特性分析
Virus Res. 2024 Dec;350:199491. doi: 10.1016/j.virusres.2024.199491. Epub 2024 Nov 9.
3
Characterization of extended-spectrum-β-lactamase producing Klebsiella pneumoniae phage KP1801 and evaluation of therapeutic efficacy in vitro and in vivo.产超广谱β-内酰胺酶肺炎克雷伯菌噬菌体 KP1801 的特性及其在体外和体内治疗效果的评价。
Sci Rep. 2020 Jul 16;10(1):11803. doi: 10.1038/s41598-020-68702-y.
4
Isolation, Identification, and Biological Characterization of Phage vB_KpnM_KpVB3 Targeting Carbapenem-Resistant Klebsiella pneumoniae ST11.针对碳青霉烯类耐药肺炎克雷伯菌 ST11 的噬菌体 vB_KpnM_KpVB3 的分离、鉴定和生物学特性研究
J Glob Antimicrob Resist. 2024 Jun;37:179-184. doi: 10.1016/j.jgar.2024.03.007. Epub 2024 Mar 30.
5
Biological characteristics and genome analysis of a novel phage vB_KpnP_IME279 infecting Klebsiella pneumoniae.一种新型噬菌体 vB_KpnP_IME279 感染肺炎克雷伯菌的生物学特性及基因组分析。
Folia Microbiol (Praha). 2020 Dec;65(6):925-936. doi: 10.1007/s12223-020-00775-8. Epub 2020 Oct 16.
6
Characterization and genome analysis of novel Klebsiella pneumoniae phage vbKpUKJ_2 isolated from hospital sewage water.从医院污水中分离出的新型肺炎克雷伯菌噬菌体vbKpUKJ_2的特性及基因组分析
BMC Microbiol. 2025 Feb 26;25(1):96. doi: 10.1186/s12866-025-03813-y.
7
Bacteriophage vB_kpnS-Kpn15: Unveiling its potential triumph against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae - Unraveling efficacy through innovative animal alternate models.噬菌体 vB_kpnS-Kpn15:揭示其针对产超广谱β-内酰胺酶的肺炎克雷伯菌的潜在胜利——通过创新的动物替代模型揭示疗效。
Microb Pathog. 2024 Oct;195:106891. doi: 10.1016/j.micpath.2024.106891. Epub 2024 Aug 28.
8
Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.从 COVID-19 患者呼吸机相关性肺炎(VAP)感染中分离的产碳青霉烯酶肺炎克雷伯菌(CRKP)中分离、鉴定、治疗效力及新型噬菌体 vB_KshKPC-M 的基因组分析。
Ann Clin Microbiol Antimicrob. 2023 Feb 24;22(1):18. doi: 10.1186/s12941-023-00567-1.
9
Characterization of Newly Isolated Bacteriophages Targeting Carbapenem-Resistant Klebsiella pneumoniae.新型靶向耐碳青霉烯类肺炎克雷伯菌的噬菌体的特性分析
J Microbiol. 2024 Dec;62(12):1133-1153. doi: 10.1007/s12275-024-00180-7. Epub 2024 Dec 10.
10
Characterization and genome analysis of novel Klebsiella phage Henu1 with lytic activity against clinical strains of Klebsiella pneumoniae.新型噬菌体 Henu1 的特性和基因组分析,该噬菌体对临床肺炎克雷伯菌具有裂解活性。
Arch Virol. 2019 Sep;164(9):2389-2393. doi: 10.1007/s00705-019-04321-x. Epub 2019 Jun 18.

本文引用的文献

1
Phenotypic and Genotypic Profiles of Extended-Spectrum Beta-Lactamase-Producing Multidrug-Resistant in Northeastern Thailand.泰国东北部产超广谱β-内酰胺酶的多重耐药菌的表型和基因型特征
Antibiotics (Basel). 2024 Sep 25;13(10):917. doi: 10.3390/antibiotics13100917.
2
TolC contributes to antimicrobial resistance, exopolysaccharide production, and virulence.托尔克(TolC)有助于抗菌药物耐药性、胞外多糖产生和毒力。
Infect Immun. 2023 Dec 12;91(12):e0030323. doi: 10.1128/iai.00303-23. Epub 2023 Nov 20.
3
Knowing and Naming: Phage Annotation and Nomenclature for Phage Therapy.
认识和命名:噬菌体注释和噬菌体治疗的命名法。
Clin Infect Dis. 2023 Nov 2;77(Suppl 5):S352-S359. doi: 10.1093/cid/ciad539.
4
Structural basis of the T4 bacteriophage primosome assembly and primer synthesis.T4 噬菌体引发体组装和引物合成的结构基础。
Nat Commun. 2023 Jul 20;14(1):4396. doi: 10.1038/s41467-023-40106-2.
5
A novel virulent Litunavirus phage possesses therapeutic value against multidrug resistant Pseudomonas aeruginosa.一种新型毒力李斯特菌噬菌体对多重耐药铜绿假单胞菌具有治疗价值。
Sci Rep. 2022 Dec 7;12(1):21193. doi: 10.1038/s41598-022-25576-6.
6
Characterization and genome analysis of Klebsiella phage P509, with lytic activity against clinical carbapenem-resistant Klebsiella pneumoniae of the KL64 capsular type.P509 噬菌体的特性与基因组分析,对 KL64 荚膜型碳青霉烯类耐药肺炎克雷伯菌具有溶菌活性。
Arch Virol. 2020 Dec;165(12):2799-2806. doi: 10.1007/s00705-020-04822-0. Epub 2020 Sep 28.
7
Identification of a newly isolated lytic bacteriophage against K24 capsular type, carbapenem resistant Klebsiella pneumoniae isolates.鉴定一种针对 K24 荚膜型、碳青霉烯类耐药肺炎克雷伯菌分离株的新型裂解噬菌体。
Sci Rep. 2020 Apr 3;10(1):5891. doi: 10.1038/s41598-020-62691-8.
8
Bacteriophages of spp., their diversity and potential therapeutic uses.种噬菌体及其多样性和潜在的治疗用途。
J Med Microbiol. 2020 Feb;69(2):176-194. doi: 10.1099/jmm.0.001141. Epub 2020 Jan 24.
9
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.抗菌药物耐药时代对抗ESKAPE病原体的新兴策略:综述
Front Microbiol. 2019 Apr 1;10:539. doi: 10.3389/fmicb.2019.00539. eCollection 2019.
10
Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101.鉴定一种新发现的针对肺炎克雷伯菌 101 型的裂解噬菌体 vB_Kpn_F48
Viruses. 2018 Sep 9;10(9):482. doi: 10.3390/v10090482.